In the TCGA AML cohort, clinical analyses (Network et al, 2013) report an NSD1–NUP98 fusion in samples TCGA-AB-2930 and TCGA-AB-2856 and an NUP98–NSD1 fusion in TCGA-AB-2930. Here, NUP98 is linked to acute myeloid leukemia.